A randomised controlled phase II trial to examine the feasibility of using hyper‐oxygenated fatty acids ( HOFA ) to prevent facial pressure injuries from medical devices among adults admitted to intensive care—A research protocol
International Wound Journal · 2024
DOI: 10.1111/iwj.70069 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift International Wound Journal, 2024. Verfasst von Leanne Hunt und 17 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Research in Collaboration and Evidence Translation, Liverpool, NSW, Australia. Hauptthemen laut MEDLINE: Feasibility Studies, Pressure Ulcer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Dekubitus, Intensivpflege
Abstract (Originalsprache)
One in three patients admitted to intensive care will sustain a pressure injury (PI) from a medical device. These injuries are painful and when on the face, head or neck they can result in permanent disfigurement. Preliminary evidence of the efficacy of hyper‐oxygenated fatty acids (HOFAs) to prevent facial pressure injuries from medical devices is promising; however, the feasibility of incorporating HOFAs into current standard care to prevent PI from a medical device of the face, head and neck has not been extensively explored. It is intended that the findings from this phase II feasibility study will inform the design of a larger phase III trial, by addressing two primary aims: (1) to assess the feasibility of incorporating HOFAs into standard care to prevent device‐related pressure ulcers of the skin associated with the face, head and neck assess the feasibility and (2) efficacy preliminary effectiveness of HOFA. This feasibility study is an investigator‐initiated mixed method study incorporating a multi‐centre randomised controlled trial of using HOFAs as an adjunct to standard pressure injury prevention and care, compared with standard care alone to prevent facial, head or neck from medical devices among adults admitted to intensive care. The primary outcome of interest is the incidence of facial, head or neck pressure injuries during the first 14 days in intensive care. Secondary outcomes include PI staging, medical device exposure and intensive care and hospital outcomes. The primary analysis will be undertaken using Cox's Proportional Hazards model, and due to the exploratory nature of this phase II trial, efficacy will be based on a one‐sided p ‐value for superiority set at 0.10. Type I and Type II error rates are set at 20%; therefore, a total sample size of 196 study participants is planned. To explore the feasibility of incorporating HOFA into usual care and to design a larger phase III trial, we will aim to interview between 10 and 20 nurses across participating intensive care unit sites. Pressure injuries of the face, head or neck from medical devices, among adults admitted to intensive care, are considered preventable. This phase II study will investigate the feasibility and efficacy of HOFAs as an adjunct to standard care. Importantly, we aim to inform the development of a larger phase III trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Critical Care Research in Collaboration and Evidence Translation, Liverpool, NSW, Australia.
- School of Nursing and Midwifery, Western Sydney University, Sydney, NSW, Australia.
- School of Nursing, Midwifery and Social Work, Queensland University, Brisbane, QLD, Australia.
- Department of Intensive Care, Bankstown-Lidcombe Hospital, Bankstown, NSW, Australia.
- Department of Intensive Care, Liverpool Hospital, Liverpool, NSW, Australia.
- School of Nursing, University of Wollongong, Wollongong, NSW, Australia.
ORCID-Profile: Steven A Frost
Zitieren
APA
Hunt, L., Ingleman, J., Brennen, K., Armstrong, K., Hazell, M., Keith, N., Bickford, B., Sanchez, D., Khalil, S., Geering, S., Sigdel, S. A., Skaria, S., Prabhakaran, S., Lynch, J., Alexandrou, E., Drury, P., Tran, T., & Frost, S. A. (2024). A randomised controlled phase II trial to examine the feasibility of using hyper‐oxygenated fatty acids ( HOFA ) to prevent facial pressure injuries from medical devices among adults admitted to intensive care—A research protocol. International Wound Journal. https://doi.org/10.1111/iwj.70069
Vancouver
Hunt L, Ingleman J, Brennen K, Armstrong K, Hazell M, Keith N, et al. A randomised controlled phase II trial to examine the feasibility of using hyper‐oxygenated fatty acids ( HOFA ) to prevent facial pressure injuries from medical devices among adults admitted to intensive care—A research protocol. International Wound Journal. 2024. doi:10.1111/iwj.70069
BibTeX
@article{Hunt2024,
author = {Hunt, Leanne and Ingleman, Jessica and Brennen, Kathleen and Armstrong, Karyn and Hazell, Mariepaz and Keith, Naomi and Bickford, Brittany and Sanchez, David and Khalil, Souti and Geering, Samara and Sigdel, Sabnam Acharya and Skaria, Santhosh and Prabhakaran, Sreeranjini and Lynch, Joan and Alexandrou, Evan and Drury, Peta and Tran, Thach and Frost, Steven A},
title = {A randomised controlled phase II trial to examine the feasibility of using hyper‐oxygenated fatty acids ( HOFA ) to prevent facial pressure injuries from medical devices among adults admitted to intensive care—A research protocol},
journal = {International Wound Journal},
year = {2024},
doi = {10.1111/iwj.70069}
}
EUVIMED